These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current Concepts in the Treatment of Renovascular Hypertension. Herrmann SM; Textor SC Am J Hypertens; 2018 Jan; 31(2):139-149. PubMed ID: 28985335 [TBL] [Abstract][Full Text] [Related]
5. How to manage hypertension with atherosclerotic renal artery stenosis? Ricco JB; Belmonte R; Illuminati G; Barral X; Schneider F; Chavent B J Cardiovasc Surg (Torino); 2017 Apr; 58(2):329-338. PubMed ID: 27998047 [TBL] [Abstract][Full Text] [Related]
6. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553 [TBL] [Abstract][Full Text] [Related]
7. Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature. Manolis AS; Manolis AA; Melita H Curr Hypertens Rev; 2017; 13(2):93-103. PubMed ID: 28782466 [TBL] [Abstract][Full Text] [Related]
8. Issues related to renal artery angioplasty and stenting. Mousa AY; Bates MC; Broce M; Bozzay J; Morcos R; AbuRahma AF Vascular; 2017 Dec; 25(6):618-628. PubMed ID: 28782453 [TBL] [Abstract][Full Text] [Related]
12. Renal artery stent fracture in patients with fibromuscular dysplasia: a cautionary tale. Raju MG; Bajzer CT; Clair DG; Kim ES; Gornik HL Circ Cardiovasc Interv; 2013 Jun; 6(3):e30-1. PubMed ID: 23780296 [No Abstract] [Full Text] [Related]
13. Percutaneous transluminal angioplasty with selective stenting for the treatment of renal artery stenosis caused by fibromuscular dysplasia: 18 years' experience from the China Center for Cardiovascular Disease. Chen Y; Dong H; Jiang X; Deng Y; Zou Y; Che W; Xiong H; Xu B; Yang Y; Gao R Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():641-647. PubMed ID: 31943685 [TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and management of renovascular hypertension and ischemic nephropathy. Yerram P; Karuparthi PR; Chaudhary K Minerva Urol Nefrol; 2012 Mar; 64(1):63-72. PubMed ID: 22402318 [TBL] [Abstract][Full Text] [Related]
16. Current approaches to renovascular hypertension. Textor SC Med Clin North Am; 2009 May; 93(3):717-32, Table of Contents. PubMed ID: 19427501 [TBL] [Abstract][Full Text] [Related]
18. Is there still a role for renal artery stenting in the management of renovascular hypertension - A single-center experience and where do we stand? Khan Z; Tolia S; Sanam K; Gholkar G; Zughaib M; Naik S; Zughaib M Cardiovasc Revasc Med; 2019 Mar; 20(3):202-206. PubMed ID: 29934065 [TBL] [Abstract][Full Text] [Related]
19. [Renovascular hypertension]. Ito S Nihon Rinsho; 2004 Mar; 62 Suppl 3():498-502. PubMed ID: 15171423 [No Abstract] [Full Text] [Related]
20. Renovascular hypertension: diagnostic and therapeutic challenges. Bosmans JL; De Broe ME JBR-BTR; 2004; 87(1):32-5. PubMed ID: 15055332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]